GreenGene™ F

BIOLOGICAL2 trials

Sponsors

Green Cross Corporation

Conditions

Hemophilia A

Phase 3

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Green Cross CorporationHemophilia A

Start: 2013-03-31End: 2015-09-30Target: 124Updated: 2014-07-03

Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A

Green Cross CorporationHemophilia A

Start: 2014-01-31End: 2016-02-29Target: 150Updated: 2014-01-06